A15-year-old girl was referred to a pediatric endocrinologist for evaluation of hyperthyroidism. Her primary concerns were intermittent increases in heart rate and appetite (with a weight gain of 7 kg within the past year), feeling hot at night even in winter, persistent lower extremity edema that had been present since age 4 years, and difficulty in concentrating. She denied having diarrhea, sweating, fatigue, breathing difficulties, hair loss, or changes in hair texture.
For 3 days, a 7-year-old girl had severe, generalized abdominal pain. The patient described the pain as sharp and achy without radiation; she denied any relieving or aggravating factors. She also reported decreased appetite and energy for the past week.
The rash on this 4-week-old girl had appeared 5 days earlier on her face as thickened scales on an erythematous base and subsequently spread to the scalp, shoulder, chest, abdomen, and extremities. A few bullae were noted on the neck and hands. Initial treatment with cephalexin failed to control the rash, and the infant was admitted to the hospital for further evaluation.
The authors on “Solitary Extramedullary Plasmacytoma of the Bladder” have provided a quick and accurate diagnosis, work-up, and treatment of this solitary extramedullary plasmacytoma. Solitary extramedullary plamacytomas are rare, and account for only 3% of all plasma cell malignancies. Of the 3% of plasma cell malignancies that are diagnosed, the bladder is one of the least common locations. The rarity of the tumor frequently makes the process of making a correct diagnosis difficult.[1] After... More »
Plasmacytoma is a rare B-lymphocyte neoplastic disorder that usually presents as the generalized disease multiple myeloma. Less than 5% of the cases present as a solitary mass of monoclonal plasma cells in the bone or soft tissue. Although solitary extramedullary plasmacytoma (SEP) may arise in any organ, it rarely involves the urinary bladder. A 67-year-old male without a history of multiple myeloma presented with urinary frequency and nocturia; he was later diagnosed with SEP of the bladder.... More »
Adding gemcitabine (Gemzar) to concurrent radiotherapy and cisplatinum in invasive bladder cancer could preserve the organ even when the tumor has invaded the muscle. More »
We report 4 cases of bladder cancer in an ethnically diverse population of about 2500 HIV-infected patients. These patients were younger than the median age at diagnosis of bladder cancer in the United States. More »
The 1990s were an exciting decade for the treatment of chronic kidney disease (CKD). The addition of angiotensin-converting enzyme inhibitors (ACEIs) and then angiotensin receptor blockers to the antihypertensive armamentarium helped preserve renal function and decrease proteinuria in patients with CKD. More »
(MAU) serum creatinine lipid profile and fasting blood glucose (FPG) were collected. Estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Diseases (MDRD) and Chronic KidneyDisease Epidemiology Collaboration (CKD-EPI) equations. ...
Cardiovascular risk scoring (Score) does not specifically address chronic kidneydisease (CKD) patients. The aim of our study is to quantify atherosclerosis using carotid ultrasound and ankle–brachial index (ABI) and to assess its additional value in risk scoring. ...
Both conditions are associated with increased mortality. Serum cystatin C is purportedly a more sensitive marker of kidneydisease and a better predictor of mortality than serum creatinine. However studies suggest that extrarenal factors also influence cystatin C levels. ... eGFRCYSC may be particularly helpful in identifying kidneydisease in the setting of anaemia among younger persons women ...
Alternatively chronic kidneydisease can be an intrinsically renal disease such as polycystic kidneydisease. Therefore at diagnosis of chronic kidneydisease family physicians must determine ...
(BKA) and above-knee amputations(AKA) and verified by reviewing medical records. We evaluated three levels of renal function: chronic kidneydisease (CKD) hemodialysis and no renal disease. ...
chemokine receptor-4 (CXCR4) was upregulated in invasive bladder cancers and that the small peptide T140 was a highly ... using urinary sediments from the patients and chemically induced mouse bladder cancer model a novel fluorescent CXCR4 antagonist TY14003 was developed ...
AIM: To describe the population-based variation in treatment policies and outcome for bladder cancer in the Netherlands. METHODS: All newly diagnosed patients with primary bladder cancers during 2001-2006 were selected from the Netherlands Cancer Registry ...
is currently being exploited to develop alternative therapeutic strategies for bladder cancer and other cancers. Previously we reported that oncolytic ... nature of the molecular defect of IFN signaling by which bladder cancer cells become susceptible to VSV infection. ...
Although several studies have assessed the association between total fluid intake specific drinks and bladder cancer no firm conclusions can yet be drawn. Four hundred thirty two bladder cancer cases and 392 frequency matched hospital-based controls recruited ...
BACKGROUND: The Asian Forum of Chronic KidneyDisease Initiative started in 2007 in Hamamatsu Japan when delegates from 16 countries joined together to facilitate collaboration in studying chronic kidneydisease (CKD) in the Asia-Pacific region. Based on the outcome of the first meeting the second meeting ...
use of tumor markers for 4 cancer sites--liver bladder cervical and gastric--were critically reviewed. ... an adjunct to imaging especially in the absence of measurable disease. Although several urine markers have been proposed for bladder...
OBJECTIVE To provide evidence-based recommendations on bladder cancer management METHODS A multidisciplinary guideline panel composed of urologists medical oncologists radiotherapists ... practice was then attended by 122 delegates of various specialities. CONCLUSION Recommendations on bladder cancer management are provided. ...